HKSH’s IVF Centre First in Hong Kong to Apply Next Generation Sequencing (NGS) to Pre-implantation Genetic Testing – Helps Infertile Couples Enhance Pregnancy Rate and Reduces the Chance of Transmitting Genetic Abnormality from Parents to Their Offspring

(27 July 2016, Hong Kong) The IVF Centre of Hong Kong Sanatorium & Hospital (“the Hospital”) has always been at the technological forefront to assist couples with infertility issues since the birth of Hong Kong’s first in vitro fertilization (IVF) baby at the Centre in 1986. In its latest initiative, the Centre has applied advanced genomic technology, Next Generation Sequencing (NGS), to pre-implantation genetic testing. Pre-implantation Genetic Screening (PGS) and Pre-implantation Genetic Diagnosis (PGD) with sophisticated NGS technology facilitate embryo selection, which in turn help enhance pregnancy rate and decrease the potential hazard of transmitting a genetic abnormality or disease from parents to their offspring.

Please click here for more information.

慎防詐騙提示：近日接獲有公眾人士指稱收到冒充養和醫院的電話，並通知有醫療文件未領取，此類通訊均為冒充來電，切勿回覆或提供個人資料。公眾人士請慎防冒充養和醫療集團或其成員包括養和醫院、養和醫健、養和東區醫療中心、養和癌症中心以及各關聯公司名義的通訊 (虛假網站、電郵或語音來電等)。如有懷疑，切勿提供個人資料，並致電2572 0211與本集團聯絡。

山村園地

桌面版

語言

最新消息

HKSH’s IVF Centre First in Hong Kong to Apply Next Generation Sequencing (NGS) to Pre-implantation Genetic Testing – Helps Infertile Couples Enhance Pregnancy Rate and Reduces the Chance of Transmitting Genetic Abnormality from Parents to Their Offspring

語言

搜尋表單

最新消息

HKSH’s IVF Centre First in Hong Kong to Apply Next Generation Sequencing (NGS) to Pre-implantation Genetic Testing – Helps Infertile Couples Enhance Pregnancy Rate and Reduces the Chance of Transmitting Genetic Abnormality from Parents to Their Offspring